RELAPSED ADULT AML
Clinical trials for RELAPSED ADULT AML explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADULT AML trials appear
Sign up with your email to follow new studies for RELAPSED ADULT AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a personalized cell therapy called CD19 CAR-T for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. The therapy involves collecting a patient's own immune cells, genetically modifyin…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC
-
New drug cocktail tested for leukemia that Won't quit
Disease control Recruiting nowThis study is testing whether adding a drug called chidamide to a standard two-drug treatment is safe and more effective for adults whose acute myeloid leukemia has come back or hasn't responded to prior therapy. The goal is to see if this three-drug combination can help more pat…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage trial is testing the safety and initial effectiveness of a new cell therapy called CLL-1 CAR-NK for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. The study will give the modified immune cells to about 24 parti…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC